| (USD) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.02M | — |
| Operating expense | — | — |
| Net income | -799.00K | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CYCN returned +56.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +206.3% |
| 1 year | +56.2% |
| 5 years | -94.3% |
| All-time high | $420.60 (Mar 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CYCN would be worth today ›No. Cyclerion Therapeutics, Inc. has not paid a dividend in the past 12 months.
Cyclerion Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol CYCN.
Cyclerion Therapeutics, Inc. is part of the Healthcare sector.
Cyclerion Therapeutics, Inc. has a market cap of 18.21M USD, based on the latest quote.